Shapelys healthcare providers consider all these factors to determine if GLP-1 medications are an appropriate and safe option for an individual's weight management plan.
Lifestyle changes: The patient has participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy
This cleavage rapidly inactivates the incretins, limiting their effectiveness in promoting intestinal homeostasis (78)
Measurable density improvement requires 16 to 24 weeks
Many are trying to address this by expanding their range of protein-rich products and creating GLP-1 companion products, but it probably wont be enough
Categorisation of Nominated Substances: Because the evaluation process is extensive and ongoing, the FDA categorises "nominated" substances that have not yet reached a final decision